FTH1 and lung carcinoma: MiR-335, miR-224-5p, and miR-19b-3p directly reduce FTH1 expression by binding to its mRNA, leading to an increase in free iron and the promotion of ferroptosis in Parkinson’s disease [201], heart failure [202], and lung cancer [203].